Citigroup
TWST icon

Citigroup’s Twist Bioscience TWST Stock Holding History

Citigroup’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,100
Closed -$38K – 6331
2022
Q2 		$38K Hold
1,100
– – ﹤0.01% 4666
2022
Q1 		$54K Buy
+1,100
New +$61K ﹤0.01% 4697
2021
Q1 		– Sell
-26,600
Closed -$3.76M – 7401
2020
Q4 		$3.76M Buy
26,600
+10,300
+63% +$1.14M ﹤0.01% 2298
2020
Q3 		$1.24M Buy
+16,300
New +$1.01M ﹤0.01% 3081

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Citigroup's TWST Position: Q2 2026 in Review

Citigroup reduced its Twist Bioscience (TWST) stake by 83% in Q2 2026, selling an estimated $24.9M and leaving 77,626 shares worth $7.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Citigroup first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. The position peaked at $21.9M in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Citigroup held 77,626 shares of Twist Bioscience worth $7.99M as of Q2 2026.
  • Citigroup sold 382,661 Twist Bioscience shares in Q2 2026, an estimated $24.9M.
  • Twist Bioscience made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1773 holding.
  • Citigroup first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
  • Citigroup's Twist Bioscience position peaked at $21.9M in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.